Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. | Director | Common Shares, no par value | 159K | $165K | $1.04 | Feb 8, 2024 | By The Bailey Family Trust |
Lineage Cell Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 75K | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Feb 8, 2024 | 1 | $100K | 4 | Feb 8, 2024 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |